Influence of drug-related problems on length of hospital stay of women with a history of preeclampsia: A multicenter study

Sinclair, 2016, Medication Safety During Pregnancy: Improving Evidence-Based Practice, J Midwifery Womens Health., 61, 52, 10.1111/jmwh.12358 De Oliveira, 2017, Adverse drug reactions in high-risk pregnant women: A prospective study, Saudi Pharm J., 25, 1073, 10.1016/j.jsps.2017.01.005 Callaghan, 2012, Severe maternal morbidity among delivery and postpartum hospitalizations in the United States, Obstet Gynecol., 120, 1029, 10.1097/AOG.0b013e31826d60c5 Berg, 2010, Pregnancy-related mortality in the United States, 1998 to 2005, Obstet Gynecol., 116, 1302, 10.1097/AOG.0b013e3181fdfb11 Creanga, 2015, Pregnancy-related mortality in the United States, 2006–2010, Obstet Gynecol., 125, 5, 10.1097/AOG.0000000000000564 Armaly, 2018, Preeclampsia: Novel Mechanisms and Potential Therapeutic Approaches, Front. Physiol., 9, 973, 10.3389/fphys.2018.00973 Mutter, 2008, Molecular mechanisms of preeclampsia, Microvasc Res., 75, 1, 10.1016/j.mvr.2007.04.009 Ferrazzani, 1994, The duration of hypertension in the puerperium of preeclamptic women: relationship with renal impairment and week of delivery, Am J Obstet Gynecol., 171, 506, 10.1016/0002-9378(94)90290-9 Yattinamani, 2017, Postpartum Recovery Trends in Women with Hypertensive Disorders of Pregnancy, J Clin Outcomes Manag., 24, 1 Firoz, 2011, Postpartum evaluation and long-term implications, Best Pract Res Clin Obstet Gynaecol., 25, 549, 10.1016/j.bpobgyn.2011.03.003 Bramham, 2013, Postpartum management of hypertension, BMJ., 346 Mikami, 2014, Post-partum recovery course in patients with gestational hypertension and pre-eclampsia, J Obstet Gynaecol Res., 40, 919, 10.1111/jog.12280 Pharmaceutical Care Network Europe Foundation (2017) Classification for Drug related problems V 8.01. PCNE Classification, 10pp. https://www.pcne.org/upload/files/215_PCNE_classification_V8-01.pdf. Blix, 2006, Characteristics of drug-related problems discussed by hospital pharmacists in multidisciplinary teams, Pharm World Sci., 28, 152, 10.1007/s11096-006-9020-z Lenssen, 2016, Analysis of drug-related problems in three departments of a German University hospital, Int J Clin Pharm., 38, 119, 10.1007/s11096-015-0213-1 Smedberg, 2016, Medication use and drug-related problems among women at maternity wards-a cross-sectional study from two Norwegian hospitals, Eur J Clin Pharmacol., 72, 849, 10.1007/s00228-016-2042-0 Fernández-Llimós, 2004, Morbidity and mortality associated with pharmacotherapy. Evolution and current concept of drug-related problems, Curr Pharm Des., 10, 3947, 10.2174/1381612043382558 Huiskes, 2017, Effectiveness of medication review: a systematic review and meta-analysis of randomized controlled trials, BMC Fam Pract., 18, 5, 10.1186/s12875-016-0577-x Hanlon, 2004, Can clinical pharmacy services have a positive impact on drug-related problems and health outcomes in community-based older adults?, Am J Geriatr Pharmacother., 2, 3, 10.1016/S1543-5946(04)90002-5 Kassirer, 2014, Imperatives, expediency, and the new diagnosis, Diagnosis., 1, 11, 10.1515/dx-2013-0004 American College of Obstetricians and Gynecologists: Task Force on Hypertension in Pregnancy.Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013; 122:1122–1131. doi: 10.1097 /01.AOG.0000437382.03963.88. Van Otterloo L,Connelly C,Gould J,Abreo A,Main E. Mothers at Risk: Factors Affecting Maternal Postpartum Length of Stay. J Perinat Neonatal Nurs.2018 Oct/Dec;32(4):303-314. doi: 10.1097/JPN.0000000000000342. Haas DM, DJ Marsh, Dang DT, et al.Prescription and Other Medication Use in Pregnancy.Obstet Gynecol.2018; 131 (5): 789-798.doi: 10.1097/AOG.0000000000002579. Murtaza, 2016, Assessment of potential drug–drug interactions and its associated factors in the hospitalized cardiac patients, Saudi Pharm J., 24, 220, 10.1016/j.jsps.2015.03.009 Krähenbühl-Melcher, 2007, Drug-related problems in hospitals: a review of the recent literature, Drug Saf., 30, 379, 10.2165/00002018-200730050-00003 Cooper, 2015, Interventions to improve the appropriate use of polypharmacy in older people: a Cochrane systematic review, BMJ Open., 5, 10.1136/bmjopen-2015-009235 Zhai, 2015, The role of the clinical pharmacist in reducing mortality in hospitalized cardiac patients: A prospective, nonrandomized controlled trial using propensity score methods, Int J Clin Pharmacol Ther., 53, 220, 10.5414/CP202111 Pardo Cabello, 2016, Drug-related mortality among inpatients: a retrospective observational study, Eur J Clin Pharmacol., 72, 731, 10.1007/s00228-016-2026-0 Coulm, 2013, Hospital length-of-stay after childbirth in France, J Gynecol Obstet Biol Reprod (Paris)., 42, 76, 10.1016/j.jgyn.2012.09.009 Mamun AA,Callaway LK,O'Callaghan MJ,Williams GM,JJ Najman,Alati R, et al. Associations of maternal pre-pregnancy obesity and excess pregnancy weight gains with adverse pregnancy outcomes and length of hospital stay. BMC Pregnancy Childbirth.2011; 6(11): 1-9. doi: 10.1186/1471-2393-11-62. Brown CM, Garovic VD. Drug treatment of hypertension in pregnancy. Drugs. 2014 Mar;74(3):283-96. doi: 10.1007/s40265-014-0187-7. PMID: 24554373; PMCID: PMC4558097. Noronha Neto, 2017, Clonidine versus Captopril for Severe Postpartum Hypertension: A Randomized Controlled Trial, PLoS One., 12, 10.1371/journal.pone.0168124 da Silva, 2019, Prevalence and profile of adverse drug reactions in high-risk pregnancy: a cohort study, BMC Pregnancy Childbirth., 19, 199, 10.1186/s12884-019-2321-8 Blumenfeld, 2015, Risk Factors for Prolonged Postpartum Length of Stay Following Cesarean Delivery, Am J Perinatol., 32, 825, 10.1055/s-0034-1543953 Larson, 2017, Missed Opportunities to Improve the Health of Postpartum Women: High Rates of Untreated Hypertension in Rural Tanzania, Matern Child Health J., 21, 407, 10.1007/s10995-016-2229-0